Conseil génétique et dépistage de l’hypertension artérielle pulmonaire – consensus du Consortium international pour les études génétiques dans l’HTAP – version française
Tài liệu tham khảo
Humbert, 2004, Treatment of pulmonary arterial hypertension, N Engl J Med, 351, 1425, 10.1056/NEJMra040291
Simonneau, 2019, Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, 53, 1801913, 10.1183/13993003.01913-2018
Humbert, 2022, 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, Eur Heart J, 43, 3618, 10.1093/eurheartj/ehac237
Humbert, 2006, Pulmonary arterial hypertension in France: results from a national registry, Am J Respir Crit Care Med, 173, 1023, 10.1164/rccm.200510-1668OC
Humbert, 2021, Sotatercept for the treatment of pulmonary arterial hypertension, N Engl J Med, 384, 1204, 10.1056/NEJMoa2024277
Frantz, 2021, TORREY, a phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension, Pulm Circ, 11, 10.1177/20458940211057071
von Romberg, 1891, On sclerosis of pulmonary arteries, Dtsch Archiv Klin Med, 48, 197
Hurdman, 2012, ASPIRE registry: assessing the spectrum of pulmonary hypertension identified at a REferral centre, Eur Respir J, 39, 945, 10.1183/09031936.00078411
McGoon, 2012, REVEAL: a contemporary US pulmonary arterial hypertension registry, Eur Respir Rev, 21, 8, 10.1183/09059180.00008211
Nichols, 1997, Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32, Nat Genet, 15, 277, 10.1038/ng0397-277
Grünig, 2000, Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene, Circulation, 102, 1145, 10.1161/01.CIR.102.10.1145
Deng, 2000, Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33, Am J Respir Crit Care Med, 161, 1055, 10.1164/ajrccm.161.3.9906051
Lane, 2000, Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension, Nat Genet, 26, 81, 10.1038/79226
Deng, 2000, Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene, Am J Hum Genet, 67, 737, 10.1086/303059
Badesch, 2010, Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry, Chest, 137, 376, 10.1378/chest.09-1140
Galiè, 2013, The fifth world symposium on pulmonary hypertension, J Am Coll Cardiol, 62, D1, 10.1016/j.jacc.2013.10.030
Hoeper, 2014, The changing landscape of pulmonary arterial hypertension and implications for patient care, Eur Respir Rev, 23, 450, 10.1183/09059180.00007814
Hoeper, 2013, Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry, Int J Cardiol, 168, 871, 10.1016/j.ijcard.2012.10.026
Eichstaedt, 2022, Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension, Respir Res, 23, 74, 10.1186/s12931-022-01987-x
Machado, 2015, Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects, Hum Mutat, 36, 1113, 10.1002/humu.22904
Southgate, 2020, Molecular genetic framework underlying pulmonary arterial hypertension, Nat Rev Cardiol, 17, 85, 10.1038/s41569-019-0242-x
Morrell, 2019, Genetics and genomics of pulmonary arterial hypertension, Eur Respir J, 53, 1801899, 10.1183/13993003.01899-2018
Larkin, 2012, Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension, Am J Respir Crit Care Med, 186, 892, 10.1164/rccm.201205-0886OC
Navas Tejedor, 2017, An homozygous mutation in KCNK3 is associated with an aggressive form of hereditary pulmonary arterial hypertension, Clin Genet, 91, 453, 10.1111/cge.12869
Eyries, 2014, EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension, Nat Genet, 46, 65, 10.1038/ng.2844
Tenorio, 2014, A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies, Clin Genet, 88, 579, 10.1111/cge.12549
Hadinnapola, 2017, Phenotypic characterisation of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension, Circulation, 136, 2022, 10.1161/CIRCULATIONAHA.117.028351
Nossent, 2018, Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease, J Heart Lung Transplant, 37, 47, 10.1016/j.healun.2017.09.022
Montani, 2016, Pulmonary veno-occlusive disease, Eur Respir J, 47, 1518, 10.1183/13993003.00026-2016
Montani, 2017, Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study, Lancet Respir Med, 5, 125, 10.1016/S2213-2600(16)30438-6
Girerd, 2010, Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation, Am J Respir Crit Care Med, 181, 851, 10.1164/rccm.200908-1284OC
Kerstjens-Frederikse, 2013, TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension, J Med Genet, 50, 500, 10.1136/jmedgenet-2012-101152
Thore, 2020, Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation, Eur Respir J, 55, 1902340, 10.1183/13993003.02340-2019
Zhu, 2018, Exome sequencing in children with pulmonary arterial hypertension demonstrates differences compared with adults, Circ Genom Precis Med, 11, e001887, 10.1161/CIRCGEN.117.001887
Galambos, 2019, Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension, Eur Respir J, 54, 1801965, 10.1183/13993003.01965-2018
Eyries, 2020, Familial pulmonary arterial hypertension by KDR heterozygous loss of function, Eur Respir J, 55, 1902165, 10.1183/13993003.02165-2019
Swietlik, 2021, Bayesian inference associates rare KDR variants with specific phenotypes in pulmonary arterial hypertension, Circ Genom Precis Med, 14, e003155, 10.1161/CIRCGEN.120.003155
Zhu, 2018, Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease, Genome Med, 10, 56, 10.1186/s13073-018-0566-x
Welch, 2020, Genetics and genomics of pediatric pulmonary arterial hypertension, Genes, 11, 1213, 10.3390/genes11101213
Montani, 2022, An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants, Eur Respir J, 60, 2200656, 10.1183/13993003.00656-2022
Wang, 2021, SOX17 loss-of-function mutation underlying familial pulmonary arterial hypertension, Int Heart J, 62, 566, 10.1536/ihj.20-711
Song, 2016, Identification of genetic defects in pulmonary arterial hypertension by a new gene panel diagnostic tool, Clin Sci, 130, 2043, 10.1042/CS20160531
van den Heuvel, 2020, Genetic evaluation in a cohort of 126 Dutch pulmonary arterial hypertension patients, Genes, 11, 1191, 10.3390/genes11101191
Tenorio Castaño, 2020, Customized massive parallel sequencing panel for diagnosis of pulmonary arterial hypertension, Genes, 11, 1158, 10.3390/genes11101158
Tsoi, 2022, Persistence of persistent pulmonary hypertension of the newborn: a case of de novo TBX4 variant, Pulm Circ, 12, e12108, 10.1002/pul2.12108
Wang, 2019, Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension, Eur Respir J, 53, 1801609, 10.1183/13993003.01609-2018
Baloira, 2016, Pulmonary arterial hypertension associated with hereditary spherocytosis and splenectomy in a patient with a mutation in the BMPR2 gene, Clin Case Rep, 4, 752, 10.1002/ccr3.610
Barozzi, 2019, A combined targeted and whole exome sequencing approach identified novel candidate genes involved in heritable pulmonary arterial hypertension, Sci Rep, 9, 1425, 10.1038/s41598-018-37277-0
Braam, 2016, Extensive pulmonary sarcoid reaction in a patient with BMPR2 associated idiopathic pulmonary arterial hypertension, Sarcoidosis Vasc Diffuse Lung Dis, 33, 182
Eichstaedt, 2020, Myeloproliferative diseases as possible risk factor for development of chronic thromboembolic pulmonary hypertension - a genetic study, Int J Mol Sci, 21, 3339, 10.3390/ijms21093339
Humbert, 2002, BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives, Eur Respir J, 20, 518, 10.1183/09031936.02.01762002
Souza, 2008, Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases, Eur Respir J, 31, 343, 10.1183/09031936.00104807
Lerche, 2019, Mutually reinforcing effects of genetic variants and interferon-beta 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients, Pulm Circ, 9, 10.1177/2045894019872192
Perrin, 2015, Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study, Eur Respir J, 46, 1211, 10.1183/13993003.00051-2015
Montani, 2015, Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease, Eur Respir J, 46, 1721, 10.1183/13993003.00814-2015
Richards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, 17, 405, 10.1038/gim.2015.30
Grünig, 2009, Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia, Circulation, 119, 1747, 10.1161/CIRCULATIONAHA.108.800938
Hinderhofer, 2014, Identification of a new intronic BMPR2-mutation and early diagnosis of heritable pulmonary arterial hypertension in a large family with mean clinical follow-up of 12 years, PLoS One, 9, e91374, 10.1371/journal.pone.0091374
Coghlan, 2014, Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study, Ann Rheum Dis, 73, 1340, 10.1136/annrheumdis-2013-203301
Yang, 2019, In search of the second hit in pulmonary arterial hypertension, Circ Res, 124, 6, 10.1161/CIRCRESAHA.118.314270
Montani, 2021, Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation, Eur Respir J, 58, 2004229, 10.1183/13993003.04229-2020
Lyle, 2016, Pulmonary hypertension in hereditary hemorrhagic telangiectasia, Chest, 149, 362, 10.1378/chest.15-0535
Margelidon-Cozzolino, 2021, Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions, ERJ Open Res, 7, 10.1183/23120541.00078-2020
Nasim, 2011, Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension, Hum Mutat, 32, 1385, 10.1002/humu.21605
Ma, 2013, A novel channelopathy in pulmonary arterial hypertension, N Engl J Med, 369, 351, 10.1056/NEJMoa1211097
Austin, 2012, Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension, Circ Cardiovasc Genet, 5, 336, 10.1161/CIRCGENETICS.111.961888
Machado, 2022, Biallelic variants of ATP13A3 cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortality, J Med Genet, 59, 906, 10.1136/jmedgenet-2021-107831
Bohnen, 2018, Loss-of-function ABCC8 mutations in pulmonary arterial hypertension, Circ Genom Precis Med, 11, e002087, 10.1161/CIRCGEN.118.002087
Potus, 2020, Novel mutations and decreased expression of the epigenetic regulator TET2 in pulmonary arterial hypertension, Circulation, 141, 1986, 10.1161/CIRCULATIONAHA.119.044320
Eichstaedt, 2017, First identification of Krüppel-like factor 2 mutation in heritable pulmonary arterial hypertension, Clin Sci, 131, 689, 10.1042/CS20160930
Eyries, 2019, Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases, Eur Respir J, 53, 1801371, 10.1183/13993003.01371-2018
Plon, 2008, Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results, Hum Mutat, 29, 1282, 10.1002/humu.20880
Limoges, 2016, Pregnancy as a possible trigger for heritable pulmonary arterial hypertension, Pulm Circ, 6, 381, 10.1086/686993
Jaliawala, 2022, A second hit? Pulmonary arterial hypertension, BMPR2 mutation, and exposure to prescription amphetamines, Pulm Circ, 12, e12053, 10.1002/pul2.12053
Girerd, 2016, Genetic counselling in a national referral centre for pulmonary hypertension, Eur Respir J, 47, 541, 10.1183/13993003.00717-2015
Wang, 2014, Early onset severe pulmonary arterial hypertension with “two-hit” digenic mutations in both BMPR2 and KCNA5 genes, Int J Cardiol, 177, e167, 10.1016/j.ijcard.2014.08.124
Rosenzweig, 2008, Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension, J Heart Lung Transplant, 27, 668, 10.1016/j.healun.2008.02.009
Elliott, 2006, Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension, Circulation, 113, 2509, 10.1161/CIRCULATIONAHA.105.601930
Benza, 2015, Endothelin-1 pathway polymorphisms affect outcome in pulmonary arterial hypertension, Am J Respir Crit Care Med, 192, 1345, 10.1164/rccm.201501-0196OC
Scelsi, 2021, BMPR2 mutations and response to inhaled or parenteral prostanoids: a case series, Pulm Circ, 11, 10.1177/20458940211037275
Boucly, 2022, Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers, Pulm Circ, 12, e12023, 10.1002/pul2.12023
Taha, 2022, Molecular genetics of pulmonary hypertension in children, Curr Opin Genet Dev, 75, 101936, 10.1016/j.gde.2022.101936
Haarman, 2020, The genetic epidemiology of pediatric pulmonary arterial hypertension, J Pediatr, 225, 65, 10.1016/j.jpeds.2020.05.051
Montani, 2018, Natural history over 8 years of pulmonary vascular disease in a patient carrying bi-allelic EIF2AK4 mutations, Am J Respir Crit Care Med, 198, 537, 10.1164/rccm.201802-0317LE
Oriaku, 2020, A novel BMPR2 mutation with widely disparate heritable pulmonary arterial hypertension clinical phenotype, Pulm Circ, 10, 10.1177/2045894020931315